Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Senti Biosciences Inc.

    NASDAQ: SNTI · Real-Time Price · USD
    2.85
    -0.01 (-0.35%)
    At close: Jun 17, 2025, 3:10 PM

    Senti Biosciences Statistics

    Share Statistics

    Senti Biosciences has 26.08M shares outstanding. The number of shares has increased by -43.21% in one year.

    Shares Outstanding

    n/a
    		 26.08M

    Shares Change (YoY)

    n/a
    		 -43.21%

    Shares Change (QoQ)

    n/a
    		 466.31%

    Owned by Institutions (%)

    n/a
    		 5.54%

    Shares Floating

    n/a
    		 7.97M

    Failed to Deliver (FTD) Shares

    n/a
    		 137

    FTD / Avg. Volume

    n/a
    		 0.14%

    Short Selling Information

    The latest short interest is 158.46K, so 0.61% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 158.46K

    Short % of Shares Out

    n/a
    		 0.61%

    Short % of Float

    n/a
    		 0.61%

    Short Ratio (days to cover)

    n/a
    		 5.6

    Valuation Ratios

    The PE ratio is -0.31 and the forward PE ratio is -1.19. Senti Biosciences's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.31

    Forward PE

    n/a
    		 -1.19

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 0.63

    P/FCF Ratio

    n/a
    		 -0.39

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Senti Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.49, with a Debt / Equity ratio of 1.31.

    Current Ratio

    n/a
    		 4.49

    Quick Ratio

    n/a
    		 4.49

    Debt / Equity

    n/a
    		 1.31

    Debt / EBITDA

    n/a
    		 -0.72

    Debt / FCF

    n/a
    		 -0.81

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,552,647.06

    Employee Count

    n/a
    		 34

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 22.78% in the last 52 weeks. The beta is 2.24, so Senti Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.24

    52-Week Price Change

    n/a
    		 22.78%

    50-Day Moving Average

    n/a
    		 3.34

    200-Day Moving Average

    n/a
    		 3.4

    Relative Strength Index (RSI)

    n/a
    		 43.22

    Average Volume (20 Days)

    n/a
    		 99,358

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -61.04M

    Net Income

    n/a
    		 -52.79M

    EBITDA

    n/a
    		 -46.94M

    EBIT

    n/a
    		 -52.79M

    Earnings Per Share (EPS)

    n/a
    		 -11.49
    Full Income Statement

    Balance Sheet

    The company has 48.28M in cash and 33.64M in debt, giving a net cash position of 14.64M.

    Cash & Cash Equivalents

    n/a
    		 48.28M

    Total Debt

    n/a
    		 33.64M

    Net Cash

    n/a
    		 14.64M

    Retained Earnings

    n/a
    		 -297.13M

    Total Assets

    n/a
    		 82.78M

    Working Capital

    n/a
    		 34.49M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -41.4M and capital expenditures -26K, giving a free cash flow of -41.42M.

    Operating Cash Flow

    n/a
    		 -41.4M

    Capital Expenditures

    n/a
    		 -26K

    Free Cash Flow

    n/a
    		 -41.42M

    FCF Per Share

    n/a
    		 -9.01
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SNTI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SNTI is $8.5, which is 192.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8.5

    Price Target Difference

    n/a
    		 192.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 18, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jul 18, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -5.41

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist